Literature DB >> 1936697

Time-related, cross-sectional and prospective follow-up of pancreatic endocrine function after pancreas allograft transplantation in type 1 (insulin-dependent) diabetic patients.

R P Robertson1, P Diem, D E Sutherland.   

Abstract

It has been established that successful pancreas transplantation in Type 1 (insulin-dependent) diabetic patients results in normal but exaggerated phasic glucose-induced insulin secretion, normal intravenous glucose disappearance rates, improved glucose recovery from insulin-induced hypoglycaemia, improved glucagon secretion during insulin-induced hypoglycaemia, but no alterations in pancreatic polypeptide responses to hypoglycaemia. However, previous reports have not segregated the data in terms of the length of time following successful transplantation and very little prospective data collected over time in individual patients has been published. This article reports that in general there are no significant differences in the level of improvement when comparing responses as early as three months post-operatively up to as long as two years post-operatively when examining the data cross-sectionally in patients who have successfully maintained their allografts. Moreover, this remarkable constancy in pancreatic islet function is also seen in a smaller group of patients who have been examined prospectively at various intervals post-operatively. It is concluded that successful pancreas transplantation results in remarkable improvements in Alpha and Beta cell but not PP cell function that are maintained for at least one to two years.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936697     DOI: 10.1007/bf00587621

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  7 in total

1.  Clinical pancreatic transplantation using the prolamine duct occlusion technique--the Munich experience.

Authors:  W Land; R Landgraf; W D Illner; D Abendroth; A Kampik; U Jensen; F P Lenhart; D Burg; G Hillebrand; L A Castro
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

2.  A 10-year experience with 290 pancreas transplants at a single institution.

Authors:  D E Sutherland; D L Dunn; F C Goetz; W Kennedy; R C Ramsay; M W Steffes; S M Mauer; R Gruessner; K C Moudry-Munns; P Morel
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

3.  Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients.

Authors:  K Osei; M L Henry; T M O'Dorisio; R J Tesi; B G Sommer; R M Ferguson
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

4.  Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.

Authors:  P Diem; J B Redmon; M Abid; A Moran; D E Sutherland; J B Halter; R P Robertson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients.

Authors:  P Diem; M Abid; J B Redmon; D E Sutherland; R P Robertson
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

6.  Effects of arginine and arginine plus somatostatin infusion on insulin release in diabetic patients submitted to pancreas allotransplantation.

Authors:  A Secchi; A E Pontiroli; E Bosi; P M Piatti; J L Touraine; L D Monti; A Gelet; J Traeger; J M Dubernard; G Pozza
Journal:  Diabete Metab       Date:  1987 Jul-Aug

7.  Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients.

Authors:  J Ostman; J Bolinder; R Gunnarsson; C Brattström; G Tydén; J Wahren; C G Groth
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

  7 in total
  2 in total

Review 1.  Pancreatic transplantation: why, when and who?

Authors:  P J Lefèbvre
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

2.  The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes.

Authors:  Marcus Lundberg; Andreas Lindqvist; Nils Wierup; Lars Krogvold; Knut Dahl-Jørgensen; Oskar Skog
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.